Chemed Corporation $CHE Shares Sold by Sanctuary Advisors LLC

Sanctuary Advisors LLC decreased its stake in shares of Chemed Corporation (NYSE:CHE) by 38.6% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,670 shares of the company’s stock after selling 1,052 shares during the period. Sanctuary Advisors LLC’s holdings in Chemed were worth $631,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. SG Americas Securities LLC increased its holdings in shares of Chemed by 773.5% during the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after buying an additional 23,436 shares during the last quarter. BNP Paribas Financial Markets boosted its holdings in Chemed by 14.5% in the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after acquiring an additional 4,430 shares during the last quarter. Abacus FCF Advisors LLC acquired a new position in Chemed in the fourth quarter valued at $5,935,000. TD Asset Management Inc grew its position in Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after acquiring an additional 22,715 shares during the period. Finally, Epoch Investment Partners Inc. grew its position in Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock valued at $137,945,000 after acquiring an additional 15,133 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 3.33% of the company’s stock.

Chemed Stock Performance

NYSE:CHE opened at $508.30 on Tuesday. The firm has a 50-day moving average of $459.92 and a two-hundred day moving average of $434.09. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The stock has a market cap of $6.75 billion, a P/E ratio of 27.70, a PEG ratio of 1.88 and a beta of 0.52. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $517.74.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is 13.08%.

Analysts Set New Price Targets

Several equities research analysts have commented on CHE shares. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada increased their target price on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Finally, Bank of America raised their price target on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $480.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.